Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Ou

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.
Nature Microbiology|November 1, 2025
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein BRyan S Roark, Andrew J Schaub, Wei Shi, et al.
The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Cell Reports|April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer baseAngela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Cell Reports|August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell SignatureCheng Cheng, Hongying Duan, Kai Xu, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Scientific Reports|February 22, 2020
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine ImmunogenLi Ou, Wing-Pui Kong, Gwo-Yu Chuang, et al.
Cell Host & Microbe|March 5, 2020
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageChen-Hsiang Shen, Brandon J DeKosky, Yicheng Guo, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Journal of Virology|April 26, 2023
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.
Nature Microbiology|November 1, 2025
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein BRyan S Roark, Andrew J Schaub, Wei Shi, et al.
The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Cell Reports|April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer baseAngela R Corrigan, Hongying Duan, Cheng Cheng, et al.
Cell Reports|August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell SignatureCheng Cheng, Hongying Duan, Kai Xu, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Scientific Reports|February 22, 2020
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine ImmunogenLi Ou, Wing-Pui Kong, Gwo-Yu Chuang, et al.
Cell Host & Microbe|March 5, 2020
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageChen-Hsiang Shen, Brandon J DeKosky, Yicheng Guo, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Journal of Virology|April 26, 2023
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.
Pageof 17